decoration decoration
Stories

GROKLAW
When you want to know more...
decoration
For layout only
Home
Archives
Site Map
Search
About Groklaw
Awards
Legal Research
Timelines
ApplevSamsung
ApplevSamsung p.2
ArchiveExplorer
Autozone
Bilski
Cases
Cast: Lawyers
Comes v. MS
Contracts/Documents
Courts
DRM
Gordon v MS
GPL
Grokdoc
HTML How To
IPI v RH
IV v. Google
Legal Docs
Lodsys
MS Litigations
MSvB&N
News Picks
Novell v. MS
Novell-MS Deal
ODF/OOXML
OOXML Appeals
OraclevGoogle
Patents
ProjectMonterey
Psystar
Quote Database
Red Hat v SCO
Salus Book
SCEA v Hotz
SCO Appeals
SCO Bankruptcy
SCO Financials
SCO Overview
SCO v IBM
SCO v Novell
SCO:Soup2Nuts
SCOsource
Sean Daly
Software Patents
Switch to Linux
Transcripts
Unix Books

Gear

Groklaw Gear

Click here to send an email to the editor of this weblog.


You won't find me on Facebook


Donate

Donate Paypal


No Legal Advice

The information on Groklaw is not intended to constitute legal advice. While Mark is a lawyer and he has asked other lawyers and law students to contribute articles, all of these articles are offered to help educate, not to provide specific legal advice. They are not your lawyers.

Here's Groklaw's comments policy.


What's New

STORIES
No new stories

COMMENTS last 48 hrs
No new comments


Sponsors

Hosting:
hosted by ibiblio

On servers donated to ibiblio by AMD.

Webmaster
Price related to risk of death perhaps? | 310 comments | Create New Account
Comments belong to whoever posts them. Please notify us of inappropriate comments.
Price related to risk of death perhaps?
Authored by: Anonymous on Tuesday, July 02 2013 @ 04:14 PM EDT

We keep being told the price is related to making a profit after the billions are spent on research and development.

But I wonder if the reality is that the price is related to the risk of death.

    The greater the risk of death of the particular ailment relative to how immediate that might occur
=
    a higher value on the drug
Desperate people are willing to spend more. To get more in debt. Take out that extra mortgage. Draw from the pension, etc.

That wouldn't surprise me at all if that's actually how Pharmaceuticals decide how to price their drugs.

If true, they are knowingly taking advantage of the situation and instead of offering a fair price are deliberately inflating the price to take advantage of the impact of the illness.

I wonder if that bothers any of the doctors working for any Pharmaceutical that prices their products with such a method.

RAS

[ Reply to This | Parent | # ]

Groklaw © Copyright 2003-2013 Pamela Jones.
All trademarks and copyrights on this page are owned by their respective owners.
Comments are owned by the individual posters.

PJ's articles are licensed under a Creative Commons License. ( Details )